Streetbeat News

Products Services

BBW

Build-A-Bear Workshop has signed an exclusive multi-year partnership with the Kansas City Chiefs, the Super Bowl LVIII champions. This deal is expected to enhance Build-A-Bear's brand visibility and potentially boost sales through exclusive merchandise collaborations.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 9:38 pm

TVTX

Travere Therapeutics announced that the FDA has granted full approval to FILSPARI (Sparsentan) for slowing kidney function decline in adults with primary IgAN. This follows positive results from the PROTECT Study, which showed significant benefits over two years compared to irbesartan.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 9:36 pm

DIS

NTDOY

PARA

SONY

Sony's CFO Hiroki Totoki admitted that the company lacks enough homegrown intellectual properties (IP), posing a challenge against rivals like Nintendo and Disney. Despite successful franchises like The Last of Us, Sony's transmedia offerings are sparse. The company aims to leverage technology and creativity, with potential growth in the anime sector through Crunchyroll.

Portfolio Pulse from Franca Quarneti

September 05, 2024 | 9:10 pm

AVGO

Broadcom Inc (NASDAQ:AVGO) reported strong Q3 earnings, beating revenue and EPS estimates. The company highlighted continued strength in AI solutions and VMware, with a positive outlook for 2024 AI revenue. Despite the positive results, AVGO shares fell 3.97% after hours.

Portfolio Pulse from Adam Eckert

September 05, 2024 | 8:48 pm

GM

TSLA

XPEV

Tesla strengthens its US market position with a 23% sales increase in August, despite a slight dip in market share. In Germany, Tesla's market share drops by 2.7%, while China's EV market sees unprecedented growth with Tesla facing strong competition from domestic brands like BYD and XPeng.

Portfolio Pulse from Surbhi Jain

September 05, 2024 | 8:35 pm

AVGO

Broadcom projects its AI-related revenue to reach $12 billion in fiscal year 2024, driven by Ethernet networking and custom accelerators for AI data centers.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 8:19 pm

CYTK

Cytokinetics, Incorporated (NASDAQ:CYTK) will present two sessions at the 2024 American College of Clinical Pharmacology Annual Meeting in Bethesda, MD, from September 8 to September 10, 2024.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 8:18 pm

AMRX

Amneal Pharmaceuticals and Shilpa Medicare have received FDA approval for BORUZU, a ready-to-use Bortezomib injection for treating multiple myeloma and mantle cell lymphoma. The product is expected to launch in Q2 2025.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 8:13 pm

BLMZ

BloomZ has entered into a business alliance agreement with CrossVision to jointly offer entertainment services. This partnership aims to leverage both companies' strengths to enhance their market presence.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 8:09 pm

VOR

Vor Bio shares have risen following the release of new clinical data that supports its strategy of using shielded transplants for targeted therapies.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 8:06 pm